Adipokines and the Risk of Reflux Esophagitis
NCT01560598 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2012-03-22
Summary
We aimed to risk faoctors for GERD and association between visceral obesity, plasma adipoline(leptin, adiponectin, IL-6, TNF-α)and development of reflux esophagitis in healthy Koreans.
Conditions
- Visceral Obesity
- Reflux Esophagitis
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2013-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
National Survey on Gastroesophageal Reflux Disease (GERD) Patients
NCT00695838 ·Status: COMPLETED
-
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773 ·Status: COMPLETED
-
Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease
NCT02114216 ·Status: COMPLETED ·Phase: NA
-
Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational
NCT01378338 ·Status: COMPLETED
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
NCT02556021 ·Status: COMPLETED ·Phase: PHASE3
-
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 ·Status: UNKNOWN
-
Comparison of Treatment Outcome and Cost-effectiveness for GERD
NCT03661151 ·Status: UNKNOWN
-
The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire
NCT00901004 ·Status: COMPLETED
-
Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease
NCT04325620 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis
NCT01733810 ·Status: COMPLETED ·Phase: NA
-
Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux Disease
NCT00698178 ·Status: COMPLETED
-
GI Reflux in Lung Transplant and Its Relationship to Chronic Rejection
NCT00455078 ·Status: COMPLETED
-
Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City
NCT06585176 ·Status: COMPLETED
-
Detection of Minimal Change Esophagitis by I-scan
NCT01560910 ·Status: COMPLETED
-
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
NCT07160790 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury
NCT01570842 ·Status: COMPLETED ·Phase: NA
-
Medical and Surgical Treatment of Esophageal Reflux
NCT00061724 ·Status: COMPLETED
-
Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux
NCT00373997 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
NCT01241149 ·Status: TERMINATED ·Phase: NA
-
What is the Predictive Value of the Reflux Impact Scale
NCT00536328 ·Status: TERMINATED
-
The Difference of Reflux Pattern Between the Patients Who Have Postprandial Reflux Symptoms
NCT02154659 ·Status: COMPLETED ·Phase: NA
-
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
NCT01574573 ·Status: TERMINATED ·Phase: NA
-
Registry to Compare Two Surgical Treatments for GERD
NCT02211105 ·Status: TERMINATED
-
Anthropometric Measures and Severity of Gastroesophageal Reflux Disease
NCT01954667 ·Status: COMPLETED
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA